Competition in the fast-growing pulsed field ablation (PFA) market has intensified with the arrival of Johnson & Johnson’s Varipulse system and new heart mapping capabilities from Boston Scientific ...
CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.” ...